All Type of News


SK Chemicals signs exclusive supply agreement of Parkinson’s treatment with Portuguese BIAL

SK Chemicals will supply treatments for Parkinson’s disease patients with motor fluctuation in Korea. SK Chemicals announced on the 5th that the company has signed a license agreement of exclusive supply of ‘Ongentys...

Daewoong takes a lead for anticancer ‘Samfenet’ on behalf of Samsung Bioepis

Daewoong Pharmaceutical(CEO Jong-Wook Lee) announced the company would launch ‘Samfenet,’ a Samsung Bioepis’ trastuzumab biosimilar on the 5th in Korea. Samfenet acquired approval from the Korean Ministry of Food and ...

“Korean pharmaceutical industry with mobility will join ‘AI soceity’”

It was anticipated the Korean pharmaceutical industry might be able to become one of the advanced pharmaceutical power in developing new drugs using AI(artificial intelligence) with their strong point called ‘mobility...

Medicine trade balance was USD 354.5 million this January

The medicine trade balance reportedly recorded USD 354.5 million deficits this January. According to the 2018 January Import and Export Status published by the Korea Customs Service, Korea exported USD 252.9 million ...

Endless supply suspensions and shortages of medicines even this March

There have been an endless series of drug shortages caused by supply suspension or manufacturing suspension even this March. The industry concerned showed Ticlodone Tab 100mg and 200mg Sanofi Aventis Korea is distrib...

Pharmacies, “We are more worried about loss of employees than personnel expenses”

The pharmacy society seems settled now as experiencing a chaos from the personnel expense issue, caused by the increase of the minimum salary to KRW 7,530, before. According to the society, pharmacy owners have repor...

“It is necessary to have effective IT management platform even in health care field”

It was suggested it would be necessary to have an efficient platform to manage administrative and personnel affairs using the information technology even in the health care field. AcuteNet CEO Fariba Anderson stresse...

“No damages will be created in the medical field by the Moon Jae-In Care”

The Ministry of Health and Welfare has put on a drive for the Moon Jae-In Care as preparing for agreements with the medical field after collecting opinions from the Korean Medical Association’s(KMA) Emergency Operatio...

U.S. FDA starts to review NDA of SK Biopharmaceuticals’ new sleep disorder treatment

SK Biopharmaceuticals(CEO Jung-Woo Cho) announced the company completed the New Drug Application(NDA) of SKL-N05(generic name: solriamfetol) that is being jointly developed with Jazz Pharmaceuticals, the world’s top p...

Well-developed incrementally modified drugs over new drugs

Incrementally modified drugs with upgraded features from existing approved products have reportedly played key roles for Korean pharmaceutical companies over new drugs which consumed a ton of funds. According to the ...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.